Royal College of Surgeons in Ireland
Accurately assessing the risk of schizophrenia conferred by rare.pdf (388.23 kB)
Download file

Accurately assessing the risk of schizophrenia conferred by rare copy-number variation affecting genes with brain function.

Download (388.23 kB)
journal contribution
posted on 2022-02-25, 15:29 authored by Soumya Raychaudhuri, Joshua M. Korn, Steven A A. McCarroll, The International Schizophrenia Consortium, David Altshuler, Pamela Sklar, Shaun Purcell, Mark J. Daly, John WaddingtonJohn Waddington

Investigators have linked rare copy number variation (CNVs) to neuropsychiatric diseases, such as schizophrenia. One hypothesis is that CNV events cause disease by affecting genes with specific brain functions. Under these circumstances, we expect that CNV events in cases should impact brain-function genes more frequently than those events in controls. Previous publications have applied "pathway" analyses to genes within neuropsychiatric case CNVs to show enrichment for brain-functions. While such analyses have been suggestive, they often have not rigorously compared the rates of CNVs impacting genes with brain function in cases to controls, and therefore do not address important confounders such as the large size of brain genes and overall differences in rates and sizes of CNVs. To demonstrate the potential impact of confounders, we genotyped rare CNV events in 2,415 unaffected controls with Affymetrix 6.0; we then applied standard pathway analyses using four sets of brain-function genes and observed an apparently highly significant enrichment for each set. The enrichment is simply driven by the large size of brain-function genes. Instead, we propose a case-control statistical test, cnv-enrichment-test, to compare the rate of CNVs impacting specific gene sets in cases versus controls. With simulations, we demonstrate that cnv-enrichment-test is robust to case-control differences in CNV size, CNV rate, and systematic differences in gene size. Finally, we apply cnv-enrichment-test to rare CNV events published by the International Schizophrenia Consortium (ISC). This approach reveals nominal evidence of case-association in neuronal-activity and the learning gene sets, but not the other two examined gene sets. The neuronal-activity genes have been associated in a separate set of schizophrenia cases and controls; however, testing in independent samples is necessary to definitively confirm this association. Our method is implemented in the PLINK software package.



John Waddington, Department of Molecular and Cellular Therapeutics, RCSI is a member of The International Schizophrenia Consortium.This article is also available at

Published Citation

Raychaudhuri S, Korn JM, McCarroll SA; International Schizophrenia Consortium [including Waddington JL], Altshuler D, Sklar P, Purcell S, Daly MJ. Accurately assessing the risk of schizophrenia conferred by rare copy-number variation affecting genes with brain function. PLoS Genetics. 2010 Sep 9;6(9). pii: e1001097.

Publication Date


PubMed ID



  • School of Pharmacy and Biomolecular Sciences